BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11906767)

  • 1. Evaluation of vaccines for atrophic rhinitis--a comparison of three challenge models.
    Magyar T; King VL; Kovács F
    Vaccine; 2002 Mar; 20(13-14):1797-802. PubMed ID: 11906767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of vaccination of sows with Bordetella-Pasteurella vaccines on the occurrence of atrophic rhinitis among their offspring after experimental infection with Bordetella bronchiseptica and toxigenic Pasteurella multocida.
    Barfod K; Pedersen KB
    Nord Vet Med; 1984; 36(11):337-45. PubMed ID: 6531207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type AP. multocida.
    Sakano T; Okada M; Taneda A; Mukai T; Sato S
    J Vet Med Sci; 1997 Jan; 59(1):55-7. PubMed ID: 9035080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on the incidence of atrophic rhinitis of vaccination of sows with a vaccine containing Pasteurella multocida toxin.
    Pedersen KB; Barfod K
    Nord Vet Med; 1982; 34(7-9):293-302. PubMed ID: 7177813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
    Yoshimura M; Honda Y; Yonemitsu E; Kuraoka K; Suenaga K
    PLoS One; 2024; 19(5):e0301688. PubMed ID: 38768145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A field evaluation of Nobi-Vac atrophic rhinitis vaccine.
    de Jong MF; Bouwkamp FT; Oosterwoud RA
    Vet Q; 1987 Jan; 9(1):49-59. PubMed ID: 3564317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica.
    Rajeev S; Nair RV; Kania SA; Bemis DA
    Vet Microbiol; 2003 Jul; 94(4):313-23. PubMed ID: 12829385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an atrophic rhinitis vaccine under controlled conditions.
    Voets MT; Klaassen CH; Charlier P; Wiseman A; Descamps J
    Vet Rec; 1992 Jun; 130(25):549-53. PubMed ID: 1496755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into the pathogenesis of atrophic rhinitis in pigs. I. Atrophic rhinitis caused by Bordetella bronchiseptica and Pasteurella multocida and the meaning of a thermolabile toxin of P. multocida.
    de Jong MF; Akkermans JP
    Vet Q; 1986 Jul; 8(3):204-14. PubMed ID: 3750802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses of piglets to Pasteurella multocida toxin and toxoid.
    van Diemen PM; de Vries Reilingh G; Parmentier HK
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):307-21. PubMed ID: 7941310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophic rhinitis vaccine composition triggers different serological profiles that do not correlate with protection.
    Magyar T; Donkó T; Kovács F
    Acta Vet Hung; 2008 Mar; 56(1):27-40. PubMed ID: 18401954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative.
    Nielsen JP; Foged NT; Sørensen V; Barfod K; Bording A; Petersen SK
    Can J Vet Res; 1991 Apr; 55(2):128-38. PubMed ID: 1832079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. aroA deleted Bordetella bronchiseptica inspiring robust mucosal immune response and provide full protection against intranasal challenge.
    Zhang Q; Hu R; Hu J; He H; Tang X; Jin M; Chen H; Wu B
    Res Vet Sci; 2013 Feb; 94(1):55-61. PubMed ID: 22892249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological potency testing of vaccines against progressive atrophic rhinitis.
    Oppling V; Kusch M; Rübmann P; Cussler K
    Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection of piglets against atrophic rhinitis by vaccinating the sow with a vaccine against Pasteurella multocida and Bordetella bronchiseptica.
    Riising HJ; van Empel P; Witvliet M
    Vet Rec; 2002 May; 150(18):569-71. PubMed ID: 12019649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of atrophic rhinitis in piglets by means of intranasal administration of a live non-AR-pathogenic Bordetella bronchiseptica vaccine.
    de Jong MF
    Vet Q; 1987 Apr; 9(2):123-33. PubMed ID: 2956754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic study and optimization of Salmonella delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model.
    Hur J; Byeon H; Lee JH
    Can J Vet Res; 2014 Oct; 78(4):297-303. PubMed ID: 25355999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of a Bordetella live vaccine on the occurrence and manifestation of atrophic rhinitis suum and the aerogenous infection burden in field strains of the agent].
    Ehser U; Mehlhorn G; Mietke H
    Dtsch Tierarztl Wochenschr; 1993 Sep; 100(9):355-9. PubMed ID: 8223236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum haptoglobin concentration in growing swine after intranasal challenge with Bordetella bronchiseptica and toxigenic Pasteurella multocida type D.
    Francisco CJ; Shryock TR; Bane DP; Unverzagt L
    Can J Vet Res; 1996 Jul; 60(3):222-7. PubMed ID: 8809387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aetiological significance of Bordetella bronchiseptica and Pasteurella multocida in atrophic rhinitis of swine.
    Pedersen KB; Barfod K
    Nord Vet Med; 1981 Dec; 33(12):513-22. PubMed ID: 7335484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.